XEROQUEL LP 50 mg, extended-release tablet 30 tablets
Brand page: Xeroquel (quetiapine) — all forms and strengths in France
Active ingredients: Quetiapine fumarate
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XEROQUEL LP 50 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) polychlortrifluoroéthylène PVC aluminium de 10 comprimé(s)
- Marketing authorisation holder
- PHARMA LAB
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60581115CIP74900328CIP133400949003280Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE QUÉTIAPINEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.